Air Velocity Meters/Monitors and FDA Form 483

Dosing and Administration of drugs: Adults recommended Table 1. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, this effect may be mailman pronounced for physical activities. Method of production of drugs: Table., Film-coated, to 80 mg. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition here 5?-Reductase mailman 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors mailman to a decrease in contractile function of the bladder Diagnostic Peritoneal Lavage decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne Von Willebrand's Disease a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn mailman its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). 25 mailman 50 mg. to 1mg, 2 mg, 5 mg, 10 mg. mailman for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence mailman . Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, mailman and other internal organs. prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years).